About us
Our expertise
Commercial >
We provide commercial consulting and advisory solutions across the product development and commercialization lifecycle.

Portfolio, Licensing & Development >

Commercialization & Growth >

Data Strategy & Analytics >

Value, Pricing & Access >
Our expertise across scientific and commercial domains delivers a collaborative and bespoke approach to maximize patient access and the commercial success of your innovations.

Value, Pricing & Access Strategy >

HEOR Evidence Generation >

Evidence Synthesis & RWE Generation >

Medical & Scientific Affairs >
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.

Asset Development >

Launch Strategy >

Digital Health & Omnichannel Strategy >

Centers of Excellence >
Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.

Advanced Clinical Technologies >

Forecasting & Financial Modeling >

Integrated Insights >
AI at Putnam

A strategic thought partner for your AI journey

Learn more
Join Putnam
Insights

Contact

Clement Francois

Partner, HTA and Market Access Operations

Clement leads the HTA and Market Access Operations team at Putnam, advising biopharmaceutical companies from early phase asset planning through launch, bringing in-depth knowledge of European payers and HTAs.

He has extensive HEOR, HTA and Market Access experience, having led HEOR teams for 15 years in a pharmaceutical company at the local and global levels (US and EU), and having served as an Executive VP for over 5 years in consulting in market access.

Clement has a MSc in Health Economics, a PhD in health sciences and has authored more than 200 articles, communications or posters in the field of HEOR, market access and epidemiology. He is also an Associate Researcher at the public health department from the university of Aix-Marseille.

Other members.

Mohan Chukkapalli

Remco op den Kelder

Chief Executive Officer

Eric Auger

Partner, VPA Practice Lead

Mariia Dronova